Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:21:28.515Z.
Calculation as of: 2026-10-06T18:21:28.515Z.
Quote observation: 2026-10-06T18:20:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8e2f3ec51e074b036058196f7f903a3cac1545bb57f25a27b7ce4fd0c255fbf9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$242.50M
EV/EBIT Ratio
N/A
TTM Avg
98.16x
3Y Avg
1055.07x
5Y Avg
378.93x
Market Cap
$243.22M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$248.31M
EV/EBIT Ratio
N/A
TTM Avg
84.29x
3Y Avg
326.94x
5Y Avg
227.75x
Market Cap
$237.69M
EV/EBIT Ratio
99.44x
TTM Avg
177.33x
3Y Avg
172.45x
5Y Avg
172.45x
Market Cap
$237.35M
EV/EBIT Ratio
N/A
TTM Avg
245.87x
3Y Avg
245.87x
5Y Avg
245.87x
Market Cap
$235.32M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | $242.02M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | N/A | 98.16x | 1055.07x | 378.93x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.22M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $239.90M | 6.47x | 4.53x | 4.53x | 4.53x |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $248.31M | N/A | 84.29x | 326.94x | 227.75x |
| Invivyd, Inc. (IVVD)vs › | $239.07M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | 99.44x | 177.33x | 172.45x | 172.45x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.35M | N/A | 245.87x | 245.87x | 245.87x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $235.32M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $248.27M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
